Anavasi Diagnostics
PrivateLast Round
Series A
Nov 2, 2022
Total Funding Raised
$23.85M
Company Overview
Anavasi Diagnostics operates in Healthcare & Life Sciences and is based in Redmond, Washington. Its latest recorded funding round was a Grant round in November 2021.
Anavasi Diagnostics is a medical technology company that develops a clinical diagnostic platform designed for the rapid diagnosis of infectious diseases at the point-of-care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anavasi Diagnostics Comparables
Compare Anavasi Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmplifiDx | 92% | |
| Novel Microdevices | 85% | |
| Kryptos Biotechnologies, Inc. | 84% |
For institutional investors. Book with your work email.
Anavasi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 2, 2022 | ||||
| Grant | Nov 9, 2021 | ||||
| Convertible Debt | Oct 1, 2021 | ||||
| Angel | Jan 1, 2021 | ||||
| Grant | Aug 1, 2020 |
For institutional investors. Book with your work email.
Anavasi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| University of Washington | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 53% MoM.
- Jun 2, 2025
Monthly visitors increased 67% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Anavasi Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anavasi Diagnostics's valuation, stock price, and market status.
Is Anavasi Diagnostics a public or private company?
Anavasi Diagnostics is a private company.
What is the current stock price of Anavasi Diagnostics?
Anavasi Diagnostics is a private company, so its shares have no public market price. Caplight tracks Anavasi Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anavasi Diagnostics worth (valuation)?
Valuation information for Anavasi Diagnostics is not publicly available.
Can I buy Anavasi Diagnostics stock?
Anavasi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anavasi Diagnostics's last funding round?
Anavasi Diagnostics's most recent funding round was Series A on November 2, 2022.
Who are the main investors in Anavasi Diagnostics?
Key investors in Anavasi Diagnostics include NIH RADx, University of Washington.
Will Anavasi Diagnostics IPO soon?
No public IPO plans have been announced for Anavasi Diagnostics.
How can I track Anavasi Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Anavasi Diagnostics's shares on secondary markets.